This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignees: Shire Human Genetic Therapies, Inc., Takeda Pharmaceutical Company Limited. Active years: 2017-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 86 
1 out of 1,226 
Years Active: 2017-2024
Title: Paul Campolieto: Innovator in CNS Delivery Systems
Introduction
Paul Campolieto is a notable inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medical science, particularly in the area of central nervous system (CNS) delivery of lysosomal enzymes. With a total of 4 patents, his work focuses on innovative methods and compositions that aim to treat lysosomal storage diseases.
Latest Patents
Among his latest patents, Campolieto has developed methods and compositions for CNS delivery of arylsulfatase A. This invention provides compositions and methods for effective treatment of lysosomal storage diseases. One of the key aspects of this invention is a stable formulation for direct CNS intrathecal administration, which includes an arylsulfatase A (ASA) protein, salt, and a polysorbate surfactant specifically for treating Metachromatic Leukodystrophy Disease. Another patent focuses on stable formulations for CNS delivery of arylsulfatase A, which includes recombinant human arylsulfatase A (rhASA) for the same effective treatment. This formulation is designed for intrathecal administration and ensures that less than 3% of the ASA protein exists in aggregated form.
Career Highlights
Throughout his career, Paul Campolieto has worked with prominent companies in the pharmaceutical industry. He has been associated with Shire Human Genetic Therapies, Inc. and Takeda Pharmaceutical Company Limited. His work in these organizations has allowed him to contribute to groundbreaking research and development in genetic therapies.
Collaborations
Campolieto has collaborated with several professionals in his field, including Nazila Salamat-Miller and Katherine Taylor. These collaborations have further enhanced his research and development efforts, leading to innovative solutions in the treatment of lysosomal storage diseases.
Conclusion
Paul Campolieto stands out as an influential inventor in the realm of CNS delivery systems. His innovative patents and contributions to the pharmaceutical industry reflect his commitment to advancing medical science and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile